- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.30 Å
- Oligo State
- hetero-1-1-1-1-1-1-1-1-1-1-mer
- Ligands
- 4 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- 1 x 6PE: 1,2-DIHEXANOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE(Non-covalent)
- 4 x CDL: CARDIOLIPIN(Non-covalent)
CDL.4: 8 residues within 4Å:- Chain A: F.334, W.441, L.442, R.443
- Chain C: R.4, I.18, H.220
- Ligands: 6PE.2
4 PLIP interactions:2 interactions with chain C, 2 interactions with chain A- Salt bridges: C:R.4, C:H.220, A:R.443
- Hydrogen bonds: A:L.442
CDL.11: 10 residues within 4Å:- Chain C: S.27, S.28, W.29, M.95
- Chain F: Q.62
- Chain G: R.39, T.40, C.43
- Ligands: PEE.12, CDL.15
7 PLIP interactions:2 interactions with chain C, 1 interactions with chain F, 4 interactions with chain G- Hydrogen bonds: C:S.28, C:S.28, F:Q.62
- Hydrophobic interactions: G:T.40
- Salt bridges: G:R.39, G:R.39, G:R.39
CDL.15: 20 residues within 4Å:- Chain C: S.28, N.31, L.35, K.226, G.230, L.233, L.234
- Chain D: Y.219, K.222, R.223, K.230
- Chain F: R.61, Q.62
- Chain G: Y.28, F.29, I.33, N.35, V.36, R.39
- Ligands: CDL.11
12 PLIP interactions:6 interactions with chain D, 4 interactions with chain G, 2 interactions with chain C- Hydrophobic interactions: D:Y.219, G:I.33, G:V.36, C:L.35, C:L.233
- Hydrogen bonds: D:K.230, D:K.230, G:N.35
- Salt bridges: D:K.222, D:R.223, D:K.230, G:R.39
CDL.19: 6 residues within 4Å:- Chain E: K.52, S.56, V.59, S.60, S.63
- Chain J: R.32
6 PLIP interactions:6 interactions with chain E- Hydrogen bonds: E:S.56, E:S.56, E:S.63
- Salt bridges: E:K.52, E:K.52, E:K.52
- 2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
HEM.5: 22 residues within 4Å:- Chain C: L.40, Q.43, I.44, G.47, L.48, L.50, A.51, R.79, H.82, A.83, A.86, F.89, T.125, A.126, G.129, Y.130, L.132, P.133, H.181, F.182, P.185, Y.272
15 PLIP interactions:15 interactions with chain C,- Hydrophobic interactions: C:L.40, C:Q.43, C:I.44, C:L.50, C:A.83, C:A.86, C:F.89, C:T.125, C:L.132, C:F.182, C:F.182
- Salt bridges: C:R.79, C:R.79
- Metal complexes: C:H.82, C:H.181
HEM.6: 18 residues within 4Å:- Chain C: W.30, G.33, L.36, H.96, V.97, R.99, S.105, W.112, G.115, V.116, L.118, L.119, H.195, L.196, L.199, S.204, N.205
- Ligands: JHB.7
22 PLIP interactions:22 interactions with chain C,- Hydrophobic interactions: C:L.36, C:L.36, C:V.97, C:W.112, C:W.112, C:W.112, C:L.118, C:L.119, C:L.196, C:L.199
- Hydrogen bonds: C:G.33, C:S.105, C:N.205
- Water bridges: C:W.30, C:F.32, C:F.32
- Salt bridges: C:H.96, C:R.99, C:R.99
- pi-Cation interactions: C:R.99
- Metal complexes: C:H.96, C:H.195
- 1 x JHB: 7-chloranyl-3-methyl-2-[4-[[4-(trifluoromethyloxy)phenyl]methyl]phenyl]-1~{H}-quinolin-4-one(Non-covalent)
- 1 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
- 2 x PEE: 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine(Non-covalent)
PEE.12: 16 residues within 4Å:- Chain C: W.29, Y.94, G.98, L.101, Y.102, Y.103, M.315, Q.321, F.324, W.325, V.328, L.331
- Chain F: Q.62
- Chain G: C.43, V.47
- Ligands: CDL.11
12 PLIP interactions:11 interactions with chain C, 1 interactions with chain F- Hydrophobic interactions: C:W.29, C:W.29, C:L.101, C:Y.103, C:F.324, C:W.325, C:V.328, C:L.331
- Hydrogen bonds: C:Y.102, C:Y.102, C:Q.321, F:Q.62
PEE.16: 16 residues within 4Å:- Chain C: I.77, L.232, I.235, M.239
- Chain D: H.199, M.203, K.206, M.207, M.210, M.211
- Chain E: Y.49, A.50, N.53, V.54, Q.57
- Chain J: D.35
9 PLIP interactions:1 interactions with chain J, 3 interactions with chain D, 2 interactions with chain E, 3 interactions with chain C- Hydrogen bonds: J:D.35
- Hydrophobic interactions: D:M.210, E:V.54, E:V.54, C:L.232, C:I.235, C:I.235
- Salt bridges: D:H.199, D:K.206
- 6 x PO4: PHOSPHATE ION(Non-functional Binders)
PO4.13: 5 residues within 4Å:- Chain C: T.58, W.134, D.170, A.258, P.260
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:W.134
PO4.20: 1 residues within 4Å:- Chain F: Y.83
2 PLIP interactions:2 interactions with chain F- Hydrogen bonds: F:Y.83, F:Y.83
PO4.21: 3 residues within 4Å:- Chain G: R.23, A.24, F.25
2 PLIP interactions:2 interactions with chain G- Hydrogen bonds: G:A.24, G:F.25
PO4.22: 4 residues within 4Å:- Chain G: H.27, Y.28, F.29, S.30
4 PLIP interactions:4 interactions with chain G- Hydrogen bonds: G:Y.28, G:F.29, G:S.30, G:S.30
PO4.23: 3 residues within 4Å:- Chain G: A.42, L.45, R.46
2 PLIP interactions:2 interactions with chain G- Hydrogen bonds: G:A.42
- Salt bridges: G:R.46
PO4.24: 4 residues within 4Å:- Chain D: E.3, L.4
- Chain H: L.47, H.51
3 PLIP interactions:2 interactions with chain D, 1 interactions with chain H- Hydrogen bonds: D:E.3, D:E.3
- Salt bridges: H:H.51
- 1 x HEC: HEME C(Non-covalent)
HEC.14: 18 residues within 4Å:- Chain D: V.31, V.35, C.36, C.39, H.40, N.104, L.108, P.109, P.110, I.115, R.119, Y.125, L.130, F.152, I.157, G.158, M.159, P.162
15 PLIP interactions:15 interactions with chain D,- Hydrophobic interactions: D:V.31, D:V.35, D:N.104, D:P.109, D:P.110, D:I.115, D:L.130, D:I.157, D:P.162
- Hydrogen bonds: D:Y.125, D:Y.125, D:G.158
- Salt bridges: D:R.119
- pi-Stacking: D:H.40
- Metal complexes: D:H.40
- 1 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)
- 1 x PX4: 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
PX4.18: 10 residues within 4Å:- Chain A: D.415, F.440
- Chain E: Y.37, T.40, T.44
- Chain J: F.13, R.14, T.16, F.19
- Ligands: 6PE.2
6 PLIP interactions:2 interactions with chain A, 1 interactions with chain J, 3 interactions with chain E- Salt bridges: A:D.415
- pi-Cation interactions: A:F.440, J:F.19, E:Y.37
- Hydrophobic interactions: E:T.44
- Hydrogen bonds: E:T.40
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Amporndanai, K. et al., Targeting the ubiquinol-reduction (Qi) site of the mitochondrial cytochrome bc1 complex for the development of next generation quinolone antimalarials. To Be Published
- Release Date
- 2021-06-30
- Peptides
- Cytochrome b-c1 complex subunit 1, mitochondrial: A
Cytochrome b-c1 complex subunit 2, mitochondrial: B
Cytochrome b: C
Cytochrome c1, heme protein, mitochondrial: D
Cytochrome b-c1 complex subunit Rieske, mitochondrial: E
Cytochrome b-c1 complex subunit 7: F
Cytochrome b-c1 complex subunit 8: G
Cytochrome b-c1 complex subunit 6, mitochondrial: H
Cytochrome b-c1 complex subunit Rieske, mitochondrial: I
Cytochrome b-c1 complex subunit 9: J - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
J - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.30 Å
- Oligo State
- hetero-1-1-1-1-1-1-1-1-1-1-mer
- Ligands
- 4 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- 1 x 6PE: 1,2-DIHEXANOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE(Non-covalent)
- 4 x CDL: CARDIOLIPIN(Non-covalent)
- 2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 1 x JHB: 7-chloranyl-3-methyl-2-[4-[[4-(trifluoromethyloxy)phenyl]methyl]phenyl]-1~{H}-quinolin-4-one(Non-covalent)
- 1 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
- 2 x PEE: 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine(Non-covalent)
- 6 x PO4: PHOSPHATE ION(Non-functional Binders)
- 1 x HEC: HEME C(Non-covalent)
- 1 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)
- 1 x PX4: 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Amporndanai, K. et al., Targeting the ubiquinol-reduction (Qi) site of the mitochondrial cytochrome bc1 complex for the development of next generation quinolone antimalarials. To Be Published
- Release Date
- 2021-06-30
- Peptides
- Cytochrome b-c1 complex subunit 1, mitochondrial: A
Cytochrome b-c1 complex subunit 2, mitochondrial: B
Cytochrome b: C
Cytochrome c1, heme protein, mitochondrial: D
Cytochrome b-c1 complex subunit Rieske, mitochondrial: E
Cytochrome b-c1 complex subunit 7: F
Cytochrome b-c1 complex subunit 8: G
Cytochrome b-c1 complex subunit 6, mitochondrial: H
Cytochrome b-c1 complex subunit Rieske, mitochondrial: I
Cytochrome b-c1 complex subunit 9: J - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
J - Membrane
-
We predict this structure to be a membrane protein.